Insulin resistance – the basics every medical specialist should know
Keywordsinsulin resistance, hyperinsulinemia, obesity
Introduction and purpose: Insulin resistance (IR) is a health problem as it can accompany obesity and lead to serious metabolic complications. In recent years, it has been "overdiagnosed" in clinical practice due to the lack of specific diagnostic criteria. The article summarizes the current knowledge in the field of pathophysiology, clinical picture and diagnostics.
State of knowledge: Obesity remains the leading cause of IR, especially in the 21st century. In a positive energy balance, the adipocyte overloaded with fat protects itself against further influx of glucose and fats and becomes insulin insensitive. A component of IR development is subclinical inflammation of macrophage-rich adipose tissue which is exacerbated by an adipocytokine imbalance, which in turn generates IR. The markers of cellular resistance to insulin are free fatty acids in the bloodstream which are responsible for the lipotoxicity in hepatocytes and myocytes. Compensatory fasting hyperinsulinemia, which is currently considered the most sensitive diagnostic criterion, provides evidence of IR. An effective method of sensitizing cells to insulin is lifestyle modification, including a low-energy diet with regular physical activity in the form of aerobic-resistance exercise. Literature recommends no pharmacological treatment of IR alone, without obesity or other concomitant diseases.
Conclusions: IR is not a separate disease, but only a pathological expression of cells' adaptation to excess of consumed energy. However, in its systemic form, when the protective mechanisms become ineffective, it induces metabolic disturbances. Only the causal treatment of IR guarantees therapeutic success.
Yazıcı D, Sezer H. Insulin Resistance, Obesity and Lipotoxicity. Advances in Experimental Medicine and Biology 2017;960:277–304. https://doi.org/10.1007/978-3-319-48382-5_12.
Choi SM, Tucker DF, Gross DN, Easton RM, Dipilato LM, Dean AS, et al. Insulin Regulates Adipocyte Lipolysis via an Akt-Independent Signaling Pathway. MOLECULAR AND CELLULAR BIOLOGY 2010;30:5009–20. https://doi.org/10.1128/MCB.00797-10.
Tokarz VL, MacDonald PE, Klip A. The cell biology of systemic insulin function. The Journal of Cell Biology 2018;217:2273. https://doi.org/10.1083/JCB.201802095.
Ahmed B, Sultana R, Greene MW. Adipose tissue and insulin resistance in obese. Biomedicine & Pharmacotherapy 2021;137:111315. https://doi.org/10.1016/J.BIOPHA.2021.111315.
Engin AB, Engin AB. What Is Lipotoxicity? Advances in Experimental Medicine and Biology 2017;960:197–220. https://doi.org/10.1007/978-3-319-48382-5_8.
Kojta I, Chacińska M, Błachnio-Zabielska A. Obesity, Bioactive Lipids, and Adipose Tissue Inflammation in Insulin Resistance. Nutrients 2020;12. https://doi.org/10.3390/NU12051305.
Poznyak A, Grechko A v, Poggio P, Myasoedova VA, Alfieri V, Orekhov AN. Molecular Sciences The Diabetes Mellitus-Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation n.d. https://doi.org/10.3390/ijms21051835.
Placzkowska S, Pawlik-Sobecka L, Kokot I, Piwowar A. Indirect insulin resistance detection: Current clinical trends and laboratory limitations. Http://BiomedPapersUpolCz/Doi/105507/Bp2019021Html 2019;163:187–99. https://doi.org/10.5507/BP.2019.021.
Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: Advantages, limitations, and appropriate usage. American Journal of Physiology - Endocrinology and Metabolism 2008;294:15–26. https://doi.org/10.1152/AJPENDO.00645.2007/ASSET/IMAGES/LARGE/ZH10010852010002.JPEG.
Mcauley KA, Williams SM, Mann JI, Walker RJ, Lewis-Barned NJ, Temple LA, et al. Diagnosing Insulin Resistance in the General Population. Diabetes Care 2001;24:460–4. https://doi.org/10.2337/DIACARE.24.3.460.
Wallace IR, Mckinley MC, Bell PM, Hunter SJ. Sex hormone binding globulin and insulin resistance 2012. https://doi.org/10.1111/cen.12086.
Kanaley JA, Colberg SR, Corcoran MH, Malin SK, Rodriguez NR, Crespo CJ, et al. Exercise/Physical Activity in Individuals with Type 2 Diabetes: A Consensus Statement from the American College of Sports Medicine. Med Sci Sports Exerc 2022;54:353–68. https://doi.org/10.1249/MSS.0000000000002800.
Pedersen SD, Wharton S. Canadian Adult Obesity Clinical Practice Guidelines 1 KEY MESSAGES FOR HEALTHCARE PROVIDERS Pharmacotherapy in Obesity Management n.d.
How to Cite
Copyright (c) 2022 Jakub Gołacki, Małgorzata Matuszek, Piotr Jarosz
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Number of views and downloads: 150
Number of citations: 0